13.27
price up icon95.43%   6.48
after-market Handel nachbörslich: 11.25 -2.02 -15.22%
loading
Schlusskurs vom Vortag:
$6.79
Offen:
$20.5
24-Stunden-Volumen:
26.91M
Relative Volume:
403.11
Marktkapitalisierung:
$617.93K
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.60M
KGV:
-4.1994
EPS:
-3.16
Netto-Cashflow:
$-8.96M
1W Leistung:
+125.68%
1M Leistung:
+110.63%
6M Leistung:
+108.65%
1J Leistung:
+65.05%
1-Tages-Spanne:
Value
$12.60
$25.58
1-Wochen-Bereich:
Value
$5.76
$25.58
52-Wochen-Spanne:
Value
$4.9176
$25.58

Artelo Biosciences Inc Stock (ARTL) Company Profile

Name
Firmenname
Artelo Biosciences Inc
Name
Telefon
858-925-7049
Name
Adresse
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Name
Mitarbeiter
6
Name
Twitter
@ArteloBio
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ARTL's Discussions on Twitter

Vergleichen Sie ARTL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ARTL
Artelo Biosciences Inc
13.27 617.93K 0 -9.60M -8.96M -3.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-02-12 Eingeleitet Ladenburg Thalmann Buy

Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten

pulisher
Jun 15, 2025

Artelo Biosciences, Inc. (NASDAQ:ARTL) Sees Significant Decline in Short Interest - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Artelo Biosciences IncRegains Nasdaq Minimum Bid Price Compliance - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Artelo Biosciences (NASDAQ:ARTL) Stock Rating Lowered by D Boral Capital - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Trading Halted for Artelo Biosciences (ARTL) as Investors Await News | ARTL Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Artelo Biosciences Engineers Reverse Stock Split - mg Magazine

Jun 12, 2025
pulisher
Jun 11, 2025

# Artelo Biosciences announces 6-for-1 reverse stock split By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

# Artelo Biosciences announces 6-for-1 reverse stock split - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences (ARTL) Downgraded to Hold by D. Boral Capital - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences stock rating cut to Hold by D. Boral Capital - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences (ARTL) Downgraded to Hold by D. Boral Capital | ARTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences to Implement 6-for-1 Reverse Stock Split; Shares Down - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences (ARTL) Downgraded to Hold Following Reverse Stock Split | ARTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences (ARTL) Initiates 6-for-1 Reverse Stock Split - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences (ARTL) Initiates 6-for-1 Reverse Stock Split | ARTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences Announces Reverse Stock Split | ARTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences, Inc. Announces 6-for-1 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Biosciences Announces Reverse Stock Split - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Artelo Sets 6-for-1 Reverse Split for June 13: Key Details on Share Consolidation Plan - Stock Titan

Jun 11, 2025
pulisher
Jun 07, 2025

Artelo Biosciences (NASDAQ:ARTL) Receives “Buy” Rating from D. Boral Capital - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Artelo Biosciences (ARTL) Receives Continued 'Buy' Rating from D. Boral Capital | ARTL Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 05, 2025

Artelo Biosciences presents promising OA pain treatment data By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Artelo Biosciences (ARTL) Highlights New FABP Inhibitor Data at British Pain Conference | ARTL Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Artelo's Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Artelo Biosciences presents promising OA pain treatment data - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Non-Opioid Pain Drug Shows Breakthrough Results: Matches Popular Painkiller Naproxen in Major Study - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Artelo Biosciences (NASDAQ:ARTL) Stock Price Down 3.7% – Should You Sell? - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

ARTL: Potential of Fabp Inhibitors in Treating Mood Disorders Hi - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Independent Study Confirms Breakthrough Potential of Artelo's Novel Anxiety DrugPhase 1 Data Coming - Stock Titan

Jun 02, 2025
pulisher
May 28, 2025

Artelo Biosciences Reports Q1 2025 Financial Results - TipRanks

May 28, 2025
pulisher
May 23, 2025

Artelo Biosciences Faces Nasdaq Compliance Challenge - TipRanks

May 23, 2025
pulisher
May 13, 2025

ARTELO BIOSCIENCES, INC. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 13, 2025
pulisher
May 10, 2025

Artelo Biosciences (ARTL) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
Apr 29, 2025

Artelo Biosciences’ (ARTL) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Artelo Biosciences (ARTL) Reports Promising Psoriasis Treatment Advances | ARTL Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models - AOL.com

Apr 28, 2025
pulisher
Apr 28, 2025

Artelo Biosciences Announces Publication of New Peer-Reviewed Re - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Artelo Biosciences Reports Positive Effects Of ART26.12 In Psoriasis Models - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12's Effectiveness in Treating Psoriasis | ARTL Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12's Effectiveness in Treating Psoriasis - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Artelo Biosciences Announces Positive Preclinical Results for Psoriasis Treatment ART26.12 in Journal of Investigative Dermatology - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Breakthrough Oral Psoriasis Treatment Matches Current Drugs in New Research, Phase 1 Results Coming - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Short Interest in Artelo Biosciences, Inc. (NASDAQ:ARTL) Grows By 58,220.0% - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

Artelo Biosciences (NASDAQ:ARTL) Shares Down 11.2% – What’s Next? - Defense World

Apr 24, 2025
pulisher
Apr 16, 2025

Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Artelo Biosciences (ARTL) Advances Novel Pain Therapy with Upcoming Data - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Artelo Biosciences (ARTL) Advances Cancer Therapy Pipeline - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 09, 2025

ARTL stock touches 52-week low at $0.85 amid market challenges - Investing.com

Apr 09, 2025
pulisher
Apr 04, 2025

D. Boral Capital Reaffirms Buy Rating for Artelo Biosciences (NASDAQ:ARTL) - Defense World

Apr 04, 2025

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Kapitalisierung:     |  Volumen (24h):